M/s. Delmaw Enterprises Ltd Pharmaceutical Import Profile — Uganda (DGFT 2022–2026)

Name: M/s. Delmaw Enterprises Ltd Pharmaceutical Import Records from India — 2 Products, $600.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

M/s. Delmaw Enterprises Ltd — Pharmaceutical Importer Profile (2026) | 2 Products, $600.0K Trade | TransData Nexus

M/s. Delmaw Enterprises Ltd

Pharmaceutical Importer · Uganda · Antihistamines & Allergy Focus · $600.0K Total Trade · DGFT Verified

M/s. Delmaw Enterprises Ltd is a pharmaceutical importer based in Uganda with a total trade value of $600.0K across 2 products in 2 therapeutic categories. Based on 12 verified import shipments from Indian Customs (DGFT) records, M/s. Delmaw Enterprises Ltd is the #1 buyer in 1 product including Cetirizine. M/s. Delmaw Enterprises Ltd sources from 1 verified Indian supplier, with Fourrts (india) Laboratories Private Limited accounting for 100.0% of imports.

M/s. Delmaw Enterprises Ltd — Import Portfolio & Supplier Network

M/s. Delmaw Enterprises Ltd import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to M/s. Delmaw Enterprises Ltd?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Fourrts (india) Laboratories Private Limited	$2.8M	76	100.0%

M/s. Delmaw Enterprises Ltd sources from 1 verified Indian supplier across 13 distinct formulations. The sourcing is highly concentrated — Fourrts (india) Laboratories Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
L montus tablets (levocetirizine	$275.0K	6
Iduplus capsules(paracetamol BP 325MG	$266.5K	7
Sucralfate & oxetacaine suspension	$252.9K	7
Paracetamol BP 500MG +chlorphenamine	$238.2K	7
Metformin tablets BP 500MG (metfil)	$225.3K	6
Potassium citrate BP 1100MG &	$212.5K	6
Haematinic capsules with choline	$211.5K	6
Quadrajel (6362 x 15g)	$211.1K	6
Sucrafil o gel (4000 x 200ML)	$210.5K	6
Fourts b capsules (6589 x 3 x 10's)	$209.6K	6
Filstat 10 (atorvastatin tablets 10MG)	$205.8K	6
Filstat 20 (atorvastatin tablets 20MG)	$203.6K	6
Sucrafil o gel (28025 x 200ML)	$36.9K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Cetirizine	Antihistamines & Allergy	$300.0K	6	0.2%	1
2	Metformin	Diabetes & Endocrine	$300.0K	6	0.1%	14

M/s. Delmaw Enterprises Ltd imports 2 pharmaceutical products across 2 categories into Uganda totaling $600.0K. The company is the #1 buyer for 1 product: Cetirizine.

M/s. Delmaw Enterprises Ltd — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

M/s. Delmaw Enterprises Ltd is a privately held pharmaceutical importer and wholesaler based in Kampala, Uganda. Established over 20 years ago, the company has built a reputation for distributing a wide range of pharmaceutical products, medical devices, and chemicals. As an ISO 9001:2005 certified entity, Delmaw Enterprises Ltd emphasizes quality management in its operations. The company is part of the Greater Artemis Life Sciences, under the Vista Group of Companies, and represents several international pharmaceutical manufacturers in Uganda, including Bliss GVS Healthcare Ltd., Fourrts Ltd., Strides Arcolab Ltd., Sance Laboratories, Universal Corporation Limited (UCL), and Xepa-Soul Pattinson (Malaysia).

The company's headquarters are located at Bombo Road, Gathani House, Kampala, Uganda. Delmaw Enterprises Ltd plays a pivotal role in Uganda's pharmaceutical distribution network, ensuring the availability of essential medicines and medical supplies across the country. By partnering with reputable international manufacturers, the company contributes significantly to the healthcare sector, addressing the diverse medical needs of the Ugandan population.

2Distribution Network

Delmaw Enterprises Ltd operates a centralized distribution model from its headquarters in Kampala. While specific details about warehouse locations and logistics capabilities are not publicly disclosed, the company's extensive import activities suggest a well-established infrastructure capable of handling significant volumes of pharmaceutical products. The company imports a diverse range of pharmaceutical formulations, including tablets, capsules, syrups, and injections, indicating a robust logistics network to manage these products efficiently. Given its strategic location in Kampala, Delmaw Enterprises Ltd is well-positioned to serve the entire Ugandan market, ensuring timely delivery of medical supplies to various regions.

3Industry Role

In Uganda's pharmaceutical supply chain, M/s. Delmaw Enterprises Ltd functions primarily as a wholesaler and importer. The company sources finished pharmaceutical formulations from international suppliers, particularly from India, and distributes these products to various stakeholders within the healthcare sector. By representing multiple international pharmaceutical manufacturers, Delmaw Enterprises Ltd acts as a key intermediary, facilitating the availability of a wide array of medical products in Uganda. This role is crucial in ensuring that healthcare providers have access to essential medicines and medical devices necessary for patient care.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — M/s. Delmaw Enterprises Ltd

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Delmaw Enterprises Ltd demonstrates a high degree of sourcing concentration, with a total import value of $600,000 USD from India across 12 shipments. The company's portfolio is entirely concentrated on two products: Cetirizine and Metformin, each accounting for $300,000 USD in imports. This indicates a strategic focus on these two therapeutic categories—Antihistamines & Allergy and Diabetes & Endocrine—suggesting that Delmaw Enterprises Ltd is capitalizing on the significant demand for these medications in the Ugandan market.

The exclusive sourcing from a single supplier, Fourrts (India) Laboratories Private Limited, which accounts for all 12 shipments, reflects a strong and stable supplier relationship. However, this single-source dependency also poses potential risks, such as supply chain disruptions or changes in supplier pricing and policies. To mitigate these risks, it would be prudent for Delmaw Enterprises Ltd to consider diversifying its supplier base and exploring alternative sources for these key products.

2Supply Chain Resilience

The resilience of Delmaw Enterprises Ltd's supply chain is closely tied to its exclusive reliance on Fourrts (India) Laboratories Private Limited for the importation of Cetirizine and Metformin. While this single-source strategy may offer benefits such as streamlined logistics and potentially favorable pricing, it also exposes the company to risks associated with supply chain disruptions, regulatory changes, or operational challenges faced by the supplier. Currently, there is no publicly available information indicating the presence of backup suppliers or alternative sourcing strategies for these critical products.

Importing Pharmaceuticals into Uganda — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Uganda

1Regulatory Authority & Framework

The National Drug Authority (NDA) is the primary regulatory body responsible for overseeing the manufacture, importation, distribution, and licensing of pharmaceutical products in Uganda. Established in 1993, the NDA operates under the National Drug Policy and Authority Act, which provides the legal framework for drug regulation in the country.

The NDA's mandate includes ensuring the safety, efficacy, and quality of medicines available in Uganda. This involves regulating the importation and exportation of drugs, conducting inspections of manufacturing facilities, and enforcing compliance with Good Manufacturing Practices (GMP). The NDA also maintains a national list of essential drugs and formulary, which guides the importation and distribution of pharmaceutical products. (nda.or.ug)

2Import Licensing & GMP

Importers of pharmaceutical products into Uganda are required to obtain an import license from the National Drug Authority (NDA). This license is essential for ensuring that imported drugs meet the regulatory standards set by the NDA. The import license can be annual, issued to regular importers such as retail pharmacies, wholesale pharmacies, pharmaceutical manufacturers, or any organization that regularly imports drugs and related substances. Provisional import permits are issued to non-regular importers for specific consignments, typically valid for one month. (businesslicences.go.ug)

M/s. Delmaw Enterprises Ltd — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

M/s. Delmaw Enterprises Ltd's focus on importing Cetirizine and Metformin aligns with the significant demand for these medications in Uganda. Cetirizine, an antihistamine, is commonly used to treat allergy symptoms, while Metformin is a first-line medication for managing type 2 diabetes. The prevalence of allergic conditions and diabetes in Uganda underscores the importance of these drugs in the country's healthcare system.

By concentrating on these therapeutic areas, Delmaw Enterprises Ltd addresses critical health concerns and contributes to improving the quality of life

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — M/s. Delmaw Enterprises Ltd

What products does M/s. Delmaw Enterprises Ltd import from India?

M/s. Delmaw Enterprises Ltd imports 2 pharmaceutical products across 2 categories. Top imports: Cetirizine ($300.0K), Metformin ($300.0K).

Who supplies pharmaceuticals to M/s. Delmaw Enterprises Ltd from India?

M/s. Delmaw Enterprises Ltd sources from 1 verified Indian suppliers. The primary supplier is Fourrts (india) Laboratories Private Limited (100.0% of imports, $2.8M).

What is M/s. Delmaw Enterprises Ltd's total pharmaceutical import value?

M/s. Delmaw Enterprises Ltd's total pharmaceutical import value from India is $600.0K, based on 12 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does M/s. Delmaw Enterprises Ltd focus on?

M/s. Delmaw Enterprises Ltd imports across 2 categories. The largest: Antihistamines & Allergy (50.0%), Diabetes & Endocrine (50.0%).

Get Full M/s. Delmaw Enterprises Ltd Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

M/s. Delmaw Enterprises Ltd

M/s. Delmaw Enterprises Ltd — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to M/s. Delmaw Enterprises Ltd?

What Formulations Does M/s. Delmaw Enterprises Ltd Import?

What Products Does M/s. Delmaw Enterprises Ltd Import?

Top Products by Import Value

M/s. Delmaw Enterprises Ltd Therapeutic Categories — 2 Specializations